KARIM BENABDELLAH EL KHLANJI-rekin lankidetzan egindako argitalpenak (6)

2023

  1. Lentiviral vectors for inducible, transactivator-free advanced therapy medicinal products: Application to CAR-T cells

    Molecular Therapy - Nucleic Acids, Vol. 32, pp. 322-339

2022

  1. Erratum: Physiological lentiviral vectors for the generation of improved CAR-T cells (Molecular Therapy - Oncolytics (2022) 25 (335–349), (S2372770522000687), (10.1016/j.omto.2022.05.003))

    Molecular Therapy - Oncolytics

  2. Physiological lentiviral vectors for the generation of improved CAR-T cells

    Molecular Therapy - Oncolytics, Vol. 25, pp. 335-349

2020

  1. Development of Cellular Models to Study Efficiency and Safety of Gene Edition by Homologous Directed Recombination Using the CRISPR/Cas9 System

    Cells, Vol. 9, Núm. 6

  2. Genome-edited adult stem cells: Next-generation advanced therapy medicinal products

    Stem Cells Translational Medicine, Vol. 9, Núm. 6, pp. 674-685

2018

  1. Comparison of Zinc Finger Nucleases Versus CRISPR-Specific Nucleases for Genome Editing of the Wiskott-Aldrich Syndrome Locus

    Human Gene Therapy, Vol. 29, Núm. 3, pp. 366-380